These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

553 related items for PubMed ID: 25969176

  • 1. The value of liver-based standardized uptake value and other quantitative 18F-FDG PET-CT parameters in neoadjuvant therapy response in patients with locally advanced rectal cancer: correlation with histopathology.
    Koç M, Kaya GÇ, Demir Y, Sürücü E, Sarioğlu S, Obuz F, Öztop İ, Görken İB, Sökmen S.
    Nucl Med Commun; 2015 Sep; 36(9):898-907. PubMed ID: 25969176
    [Abstract] [Full Text] [Related]

  • 2. Response to neoadjuvant therapy in locally advanced rectal cancer: assessment with diffusion-weighted MR imaging and 18FDG PET/CT.
    Ippolito D, Monguzzi L, Guerra L, Deponti E, Gardani G, Messa C, Sironi S.
    Abdom Imaging; 2012 Dec; 37(6):1032-40. PubMed ID: 22270580
    [Abstract] [Full Text] [Related]

  • 3. The predictive role of sequential FDG-PET/CT in response of locally advanced rectal cancer to neoadjuvant chemoradiation.
    Huh JW, Min JJ, Lee JH, Kim HR, Kim YJ.
    Am J Clin Oncol; 2012 Aug; 35(4):340-4. PubMed ID: 21422901
    [Abstract] [Full Text] [Related]

  • 4. Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy.
    Capirci C, Rampin L, Erba PA, Galeotti F, Crepaldi G, Banti E, Gava M, Fanti S, Mariani G, Muzzio PC, Rubello D.
    Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1583-93. PubMed ID: 17503039
    [Abstract] [Full Text] [Related]

  • 5. New application of dual point 18F-FDG PET/CT in the evaluation of neoadjuvant chemoradiation response of locally advanced rectal cancer.
    Yoon HJ, Kim SK, Kim TS, Im HJ, Lee ES, Kim HC, Park JW, Chang HJ, Choi HS, Kim DY, Oh JH.
    Clin Nucl Med; 2013 Jan; 38(1):7-12. PubMed ID: 23242038
    [Abstract] [Full Text] [Related]

  • 6. Comparison of (18)F-FDG PET/CT methods of analysis for predicting response to neoadjuvant chemoradiation therapy in patients with locally advanced low rectal cancer.
    Altini C, Niccoli Asabella A, De Luca R, Fanelli M, Caliandro C, Quartuccio N, Rubini D, Cistaro A, Montemurro S, Rubini G.
    Abdom Imaging; 2015 Jun; 40(5):1190-202. PubMed ID: 25348731
    [Abstract] [Full Text] [Related]

  • 7. Liver metabolic activity changes over time with neoadjuvant therapy in locally advanced rectal cancer.
    Demir Y, Sürücü E, Şengöz T, Koç M, Kaya GÇ.
    Nucl Med Commun; 2016 Feb; 37(2):116-21. PubMed ID: 26440564
    [Abstract] [Full Text] [Related]

  • 8. Does baseline [18F] FDG-PET/CT correlate with tumor staging, response after neoadjuvant chemoradiotherapy, and prognosis in patients with rectal cancer?
    Deantonio L, Caroli A, Puta E, Ferrante D, Apicella F, Turri L, Sacchetti G, Brambilla M, Krengli M.
    Radiat Oncol; 2018 Oct 25; 13(1):211. PubMed ID: 30359275
    [Abstract] [Full Text] [Related]

  • 9. Prediction of response to neoadjuvant radiotherapy in patients with locally advanced rectal cancer by means of sequential 18FDG-PET.
    Everaert H, Hoorens A, Vanhove C, Sermeus A, Ceulemans G, Engels B, Vermeersch M, Verellen D, Urbain D, Storme G, De Ridder M.
    Int J Radiat Oncol Biol Phys; 2011 May 01; 80(1):91-6. PubMed ID: 20605358
    [Abstract] [Full Text] [Related]

  • 10. Positron emission tomography for predicting pathologic response after neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
    Chennupati SK, Quon A, Kamaya A, Pai RK, La T, Krakow TE, Graves E, Koong AC, Chang DT.
    Am J Clin Oncol; 2012 Aug 01; 35(4):334-9. PubMed ID: 21422989
    [Abstract] [Full Text] [Related]

  • 11. The role of dual-time combined 18-fluorodeoxyglucose positron emission tomography and computed tomography in the staging and restaging workup of locally advanced rectal cancer, treated with preoperative chemoradiation therapy and radical surgery.
    Capirci C, Rubello D, Pasini F, Galeotti F, Bianchini E, Del Favero G, Panzavolta R, Crepaldi G, Rampin L, Facci E, Gava M, Banti E, Marano G.
    Int J Radiat Oncol Biol Phys; 2009 Aug 01; 74(5):1461-9. PubMed ID: 19419820
    [Abstract] [Full Text] [Related]

  • 12. The value of 18F-FDG PET/CT for assessing the response to neoadjuvant therapy in locally advanced rectal cancer.
    Murcia Duréndez MJ, Frutos Esteban L, Luján J, Frutos MD, Valero G, Navarro Fernández JL, Mohamed Salem L, Ruiz Merino G, Claver Valderas MA.
    Eur J Nucl Med Mol Imaging; 2013 Jan 01; 40(1):91-7. PubMed ID: 23081822
    [Abstract] [Full Text] [Related]

  • 13. The role of sequential 18(F) -FDG PET/CT in predicting tumour response after preoperative chemoradiation for rectal cancer.
    Sun W, Xu J, Hu W, Zhang Z, Shen W.
    Colorectal Dis; 2013 May 01; 15(5):e231-8. PubMed ID: 23384167
    [Abstract] [Full Text] [Related]

  • 14. Standardized Index of Shape (DCE-MRI) and Standardized Uptake Value (PET/CT): Two quantitative approaches to discriminate chemo-radiotherapy locally advanced rectal cancer responders under a functional profile.
    Petrillo A, Fusco R, Petrillo M, Granata V, Delrio P, Bianco F, Pecori B, Botti G, Tatangelo F, Caracò C, Aloj L, Avallone A, Lastoria S.
    Oncotarget; 2017 Jan 31; 8(5):8143-8153. PubMed ID: 28042958
    [Abstract] [Full Text] [Related]

  • 15. 18F-FDG PET is an early predictor of pathologic tumor response to preoperative radiochemotherapy in locally advanced rectal cancer.
    Cascini GL, Avallone A, Delrio P, Guida C, Tatangelo F, Marone P, Aloj L, De Martinis F, Comella P, Parisi V, Lastoria S.
    J Nucl Med; 2006 Aug 31; 47(8):1241-8. PubMed ID: 16883000
    [Abstract] [Full Text] [Related]

  • 16. Early metabolic response to neoadjuvant letrozole, measured by FDG PET/CT, is correlated with a decrease in the Ki67 labeling index in patients with hormone receptor-positive primary breast cancer: a pilot study.
    Ueda S, Tsuda H, Saeki T, Omata J, Osaki A, Shigekawa T, Ishida J, Tamura K, Abe Y, Moriya T, Yamamoto J.
    Breast Cancer; 2011 Oct 31; 18(4):299-308. PubMed ID: 20617404
    [Abstract] [Full Text] [Related]

  • 17. Prediction of neoadjuvant radiation chemotherapy response and survival using pretreatment [(18)F]FDG PET/CT scans in locally advanced rectal cancer.
    Bang JI, Ha S, Kang SB, Lee KW, Lee HS, Kim JS, Oh HK, Lee HY, Kim SE.
    Eur J Nucl Med Mol Imaging; 2016 Mar 31; 43(3):422-31. PubMed ID: 26338180
    [Abstract] [Full Text] [Related]

  • 18. Predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using 18FDG-PET/CT.
    Shanmugan S, Arrangoiz R, Nitzkorski JR, Yu JQ, Li T, Cooper H, Konski A, Farma JM, Sigurdson ER.
    Ann Surg Oncol; 2012 Jul 31; 19(7):2178-85. PubMed ID: 22395978
    [Abstract] [Full Text] [Related]

  • 19. Is the standardized uptake value of FDG-PET/CT predictive of pathological complete response in locally advanced rectal cancer treated with capecitabine-based neoadjuvant chemoradiation?
    Bampo C, Alessi A, Fantini S, Bertarelli G, de Braud F, Bombardieri E, Valvo F, Crippa F, Di Bartolomeo M, Mariani L, Milione M, Biondani P, Avuzzi B, Chiruzzi C, Pietrantonio F.
    Oncology; 2013 Jul 31; 84(4):191-9. PubMed ID: 23328390
    [Abstract] [Full Text] [Related]

  • 20. Textural Parameters of Tumor Heterogeneity in ¹⁸F-FDG PET/CT for Therapy Response Assessment and Prognosis in Patients with Locally Advanced Rectal Cancer.
    Bundschuh RA, Dinges J, Neumann L, Seyfried M, Zsótér N, Papp L, Rosenberg R, Becker K, Astner ST, Henninger M, Herrmann K, Ziegler SI, Schwaiger M, Essler M.
    J Nucl Med; 2014 Jun 31; 55(6):891-7. PubMed ID: 24752672
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.